Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03316456 · ClinicalTrials.gov registry record
Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction
A clinical trial, sponsored by Masonic Cancer Center, University of Minnesota.
- Completed
- Registry status
- 20
- Enrollment target
NCT03316456: Completed study, sponsored by Masonic Cancer Center, University of Minnesota.
NCT03316456 is a clinical trial that has completed, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03316456 has completed, sponsored by Masonic Cancer Center, University of Minnesota.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This is an observational study to collect stool, blood, and urine from acute leukemia patients undergoing induction chemotherapy in order to generate preliminary data regarding the association between microbiota and chemotherapy-induced gut barrier damage. This study consists of inpatient collections of blood, urine, and stool while the patients are undergoing inpatient induction therapy. Patients will not be scheduled for any additional procedures or testing beyond what is required for clinical care.
Primary Outcome
Variation of gut microbiota composition and diversity, as determined by 16s rRNA sequencing of serial stool samples, during induction chemotherapy in acute leukemia patients.
Interventions
- DIAGNOSTIC_TEST Observational: Stool Sample Collection
- DIAGNOSTIC_TEST Observational: Blood Sample Collection
- DIAGNOSTIC_TEST Observational: Urine Sample Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-08-22 |
| Est. Completion | 2019-04-01 |
What the finished NCT03316456 record still lists
NCT03316456 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Observational: Stool Sample Collection is the first listed.
NCT03316456 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03316456 about?
NCT03316456 is a clinical study titled "Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction". This is an observational study to collect stool, blood, and urine from acute leukemia patients undergoing induction chemotherapy in order to generate preliminary data regarding the association between microbiota and chemotherapy-induced gut barrier damage. This study consists of inpatient collection...
What is the current status of trial NCT03316456?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2017-08-22. Estimated completion is 2019-04-01.
What interventions are being tested in trial NCT03316456?
The interventions under investigation include: Observational: Stool Sample Collection (DIAGNOSTIC_TEST), Observational: Blood Sample Collection (DIAGNOSTIC_TEST), Observational: Urine Sample Collection (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03316456?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI